Immunomodulatory analogs of thalidomide inhibit growth of Hs Sultan cells and angiogenesis in vivo
Author:
Lentzsch S,LeBlanc R,Podar K,Davies F,Lin B,Hideshima T,Catley L,Stirling D I,Anderson K C
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference17 articles.
1. Vacca, A, Ribatti, D, Presta, M, Minischetti, M, Iurlaro, M, Ria, R, Albini, A, Bussolino, F & Dammacco, F. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood, (1999). 93, 3064–3073. 2. Ribatti, D, Vacca, A, Nico, B, Quondamatteo, F, Ria, R, Minischetti, M, Marzullo, A, Herken, R, Roncali, L & Dammacco, F. Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma. Br J Cancer, (1999). 79, 451–455. 3. Rajkumar, SV, Leong, T, Roche, PC, Fonseca, R, Dispenzieri, A, Lacy, MQ, Lust, JA, Witzig, TE, Kyle, RA, Gertz, MA & Greipp, PR Prognostic value of bone marrow angiogenesis in multiple myeloma. Clin Cancer Res, (2000). 6, 3111–3116. 4. D'Amato, RJ, Loughman, MS, Flynn, E & Folkman, J Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA, (1994). 91, 4082–4085. 5. Singhal, S, Mehta, J, Desikan, R, Ayers, D, Roberson, P, Eddlemon, P, Munshi, N, Anaissie, E, Wilson, C, Dhodapkar, M, Zeddis, J & Barlogie, B Anti-tumor activity of thalidomide in refractory multiple myeloma. N Engl J Med, (1999). 341, 1565–1571.
Cited by
146 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|